The purpose of this study was to explore the epidemiology of hepatitis C virus (HCV) infection and to determine the risk factors for HCV infection among heroin abusers in Taiwan.
I n 2002, chronic liver disease and liver cirrhosis were the sixth leading causes of death in Taiwan, 1 with hepatitis B and hepatitis C virus (HCV) infections the leading cause of these diseases. [2] [3] [4] In Taiwan, HCV infection is mainly transmitted by blood transfusion, IV drug abuse, accidental needle injection, sexual contact, acupuncture, tattoos, and earlobe piercing. [5] [6] [7] [8] [9] [10] Since there is no effective vaccination to prevent HCV infection, intervention consists of avoidance techniques only. After screening for HCV antibodies in blood donors was instituted in Taiwan in July 1992, the transmission of the HCV virus via blood transfusion was effectively interrupted. 11, 12 HCV is a common infection among injecting drug abusers. 2, 13 In the study by Chang et al, 8 the prevalence of anti-HCV antibody positivity was 66.4% among injecting drug abusers. Policies and programs to prevent HCV infection remain uncertain in these high risk people.
We hope to make a dent in the rising epidemic of HCV infection by monitoring HCV infection rates, as a means of showing the effectiveness of various interventions. This study used data collected from heroin abusers to explore the following questions: (1) what are the sociodemographic patterns and the prevalence of HCV infection in heroin abusers? (2) what are the risk factors for HCV infection in heroin abusers?
Materials and Methods

Study Population
This was a cross-sectional study. The study was undertaken at a male prison in Taiwan from November 2004 to February 2005. All new sentenced prisoners received a structured questionnaire interview. A total of 577 men were enrolled in the study. Of that group, 423 (73.3%) injected heroin and 154 (26.7%) smoked heroin. The study was approved by the ethics committee. The subjects' age, employment, years of education, and marital status were included. A face-to-face interview inquired about the age of first heroin use, frequency of use, duration of use, and needle sharing. Other risk factors included the number of female sexual partners, frequency of condom use, tattoo history, alcohol use, and blood transfusion history. All study subjects underwent testing for hepatitis C virus antibody using the third generation EIA test.
Statistical Analysis
Statistical analysis was performed by SPSS (Chinese Version 10.0, Sinter Information Corp, Taiwan). The t test, 2 test and multivariate logistic regression were used. Relative risks were estimated by the odds ratio (OR) using a multivariate logistic regression and were expressed with 95% confidence interval (CI). A P value less than 0.05 was considered statistically significant.
Results
Sociodemographic characteristics of this study population are listed in Table 1 . The mean age was 33.3 Ϯ 7.9 years (age range 19 -65 years). Among 68.9% of these abusers, the age of the first heroin use was less than 30 years old. Eighty percent of the abusers were employed full time, 60.3% had less than 9 years of education, and 58.2% were unmarried.
The related factors of HCV infection are listed in Table  2 . The overall prevalence of anti-HCV antibody positivity was 74.9%. The prevalence of anti-HCV antibody positivity was higher among injecting heroin abusers than among smoking heroin abusers, with statistical significance (89.8% versus 33.8%, P Ͻ 0.0001). The subjects with anti-HCV antibody positivity were younger than those who were anti-HCV antibody negative, with statistical significance (32.8 versus 34.9 years old, P ϭ 0.005). The prevalence of anti-HCV positivity did not increase with age (P ϭ 0.169).
The mean age of first heroin use and history of needle sharing were significantly associated with anti-HCV positivity. The mean age of the first heroin use was 26.8 years for the anti-HCV positive subjects, and 28.7 years for the anti-HCV negative subjects (P ϭ 0.007). Also, 93.1% of those with a needle sharing history were anti-HCV positive, compared with 70.8% of those who did not share needles. (P Ͻ 0.0001).
The employment status, years of education, marital status, frequency of use, duration of use, number of female sex partners, condom use, tattoo history, alcohol use, and blood transfusion history were not significantly associated with anti-HCV positivity.
The predictors of HCV infection are exhibited in Table 3 . In the final model, multivariate logistic regression revealed that needle sharing was the only strong risk factor for HCV infection. That is, the prevalence of anti-HCV positivity increased 5.25-fold for heroin abusers with a history of needle sharing (95% confidence interval ϭ 2.48 -11.12, P Ͻ 0.0001).
Discussion
Our study revealed that HCV is a common infection among injecting heroin abusers. The prevalence of anti-HCV positivity was 89.8% among male injecting heroin abusers. Several studies have reported similar results. The prevalence of anti-HCV positivity among injecting drug abusers was 66.4% in southern Taiwan, 8 82% in the US, 14 and 75.3% in Australia. 15 In contrast, the prevalence of anti-HCV positivity among male smoking heroin abusers was 33.8% in our study and 14.4% among noninjecting drug abusers in southern Taiwan. 8 The prevalence of anti-HCV positivity was 3.9% in a hospital-based study of healthy men. 16 Although there are variations in prevalence, HCV infection among injecting drug abusers is a critical public health threat.
Our study also confirmed that needle sharing was an independent risk factor for HCV infection (OR ϭ 5.25, 95% CI ϭ 2.48-11.12). Several studies have consistently observed this association between needle sharing and HCV infection. [17] [18] [19] [20] Hence, risk reduction programs, including use of sterile needles, is of great concern.
We also found the mean age of the first heroin use for the subjects with anti-HCV positivity was younger than those who were anti-HCV negative (26.8 versus 28.7 years old, P ϭ 0.007). We also noted that the cumulative prevalence of anti-HCV positivity reached an apparently high level (82.2%) before 40 years of age. Due to the fact that the number of heroin users with anti-HCV positivity was highest among those who began using before age 30, and among those with less education, risk reduction counseling must be directed at these specific sociodemographic groups. Surprisingly, we identified that tattooing was not associated with anti-HCV positivity in the 2 test (P ϭ 0.225). So far, no consistent data exist for the association between tattooing and HCV infection. In the study by Alter et al, 21 no association was found between tattooing and HCV infection. In contrast, however, several researchers have illustrated a a Imprecise summation of total subjects was due to missing data.
remarkable association between tattooing and HCV infection. 5,6,8 -10 Ko et al also suspected that unhygienic tattooing with improperly sterilized needles could obviously introduce an increased risk for HCV infection in Taiwan.
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Limitations
Due to the small sample size, this is not a thorough representation of all Taiwanese heroin abusers. However, 70.8% of those without a needle sharing history were also anti-HCV positive. Thus, there is un urgent need to investigate the other routes of transmission of HCV. Hence, a larger detailed study is necessary for a more accurate description of risk factors.
Conclusion
The prevalence of anti-HCV positivity among male injecting drug abusers is predominantly high. The parenteral route, mainly by needle sharing, is the most common transmission route of HCV infection. Intervention to improve the availability of sterile needles is a critical public health topic with regard to reducing HCV infections in Taiwan. Moreover, we sincerely hope this study could provide the background data for further decision making in public health care policy. 
